Previous studies found EP2/Gαs coupled with PGE2 exerted proneoplastic effects by stimulating critical oncogenic pathways, such as the GSK3β/β-catenin pathway[30] and cAMP/PKA pathway[31] in colon[8], lung[32] and prostate cancer[33]. The gene discussed is GSK3B; the disease is prostate carcinoma.